Learn about the global coronavirus (COVID-19) current therapy market through The Business Research Company, which provides information on coronavirus (COVID-19) current therapy market size, coronavirus (COVID-19) current therapy market drivers and restraints, coronavirus (COVID-19) current therapy market players, the COVID-19 impact on the coronavirus (COVID-19) current therapy market, and more.

The global coronavirus (COVID-19) current therapy market is expected to decline from $28.16 billion in 2021 to $16.43 billion in 2022 at a compound annual growth rate (CAGR) of -41.7%. The decline in the COVID-19 current therapy market growth is mainly due to the companies resuming their operations and adapting to the new normal while recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The COVID-19 current therapy market is expected to decline to $1.57 billion in 2026 at a CAGR of -44.4%.

Request A Sample For The Global Coronavirus (COVID-19) Current Therapy Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3247&type=smp

The coronavirus (COVID-19) current therapy market consists of sales of drugs currently used for the treatment of COVID-19 infection. The market report includes single-drug therapeutics and combination drug therapeutics used in treating COVID-19 patients. The market consists of revenue generated by the companies that manufacture coronavirus current therapeutics by the sales of these products.

Global Coronavirus (COVID-19) Current Therapy Market Segments Include:

By Drug Type: Remdesivir, Hydroxychloroquine, Ritonavir, Lopinavir, Interferon Beta, Others

By Route of Administration: Oral, Intravenous

By End-User: Hospitals, Clinics, Research Institutes, Others

By Geography: The market is segmented into North America, South America, Asia-Pacific, Eastern Europe, Western Europe, Middle East and Africa. Among these regions, North America is the largest region in the coronavirus (COVID-19) current therapy market in 2021.

Convalescent Plasma Therapy is used as an experimental therapy to treat COVID-19 patients. The blood plasma of patients who have recovered from a disease is called convalescent plasma (CP). Convalescent Plasma therapy is a type of passive antibody therapy in which blood plasma is isolated from patients who have recovered from the disease of interest and administered to the patient with severe disease to suppress the virulence and improve clinical symptoms.

TBRC’s coronavirus (COVID-19) current therapy market report covers:

Major Market Players: Moderna Therapeutics, Novavax, Bravovax, Ascletis Pharma, Altimmune, Clover Biopharmaceuticals, Inovio Pharmaceuticals, Inc., Biocryst Pharma, Gilead Sciences, and Regeneron Pharmaceuticals.

Regions: Asia-Pacific, China, Western Europe, Eastern Europe, North America, USA, South America, Middle East and Africa.

Countries: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

Time Series: Five years historic (2016-21) and ten years forecast (2022-2026-2031)

The Coronavirus (COVID-19) Current Therapy Global Market Report 2022 –Market Size, Trends, And Global Forecast 2022-2026 is one of a series of new reports from The Business Research Company that provides coronavirus (COVID-19) current therapy market overviews, analyses and forecasts market size, share, coronavirus (COVID-19) current therapy market players, coronavirus (COVID-19) current therapy market segments and geographies, leading competitor revenues, profiles and market shares.

TBRC’s coronavirus (COVID-19) current therapy market report identifies top countries and segments for opportunities and strategies based on market trends and leading competitors’ approaches.

Here Is A List Of Similar Reports From The Business Research Company:

Remdesivir Global Market Report 2022

COVID-19 Drug Associated APIs Global Market Report 2022

COVID-19 Detection Test Kits And Consumables Global Market Report 2021

Interested To Know More About The Business Research Company?
The Business Research Company has published over 1000 industry reports, covering over 2500 market segments and 60 geographies. The reports draw on 150,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders. The reports are updated with a detailed analysis of the impact of COVID-19 on various markets.

Read more about us at https://www.thebusinessresearchcompany.com/about-the-business-research-company.aspx

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow us on LinkedIn: https://in.linkedin.com/company/the-business-research-company
Follow us on Twitter: https://twitter.com/tbrc_info
Check out our Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: